373 related articles for article (PubMed ID: 28493631)
21. Effectiveness of subcutaneous versus sublingual immunotherapy for the treatment of allergic rhinoconjunctivitis and asthma: a systematic review.
Chelladurai Y; Suarez-Cuervo C; Erekosima N; Kim JM; Ramanathan M; Segal JB; Lin SY
J Allergy Clin Immunol Pract; 2013; 1(4):361-9. PubMed ID: 24565541
[TBL] [Abstract][Full Text] [Related]
22. EAACI Guidelines on Allergen Immunotherapy: Allergic rhinoconjunctivitis.
Roberts G; Pfaar O; Akdis CA; Ansotegui IJ; Durham SR; Gerth van Wijk R; Halken S; Larenas-Linnemann D; Pawankar R; Pitsios C; Sheikh A; Worm M; Arasi S; Calderon MA; Cingi C; Dhami S; Fauquert JL; Hamelmann E; Hellings P; Jacobsen L; Knol EF; Lin SY; Maggina P; Mösges R; Oude Elberink JNG; Pajno GB; Pastorello EA; Penagos M; Rotiroti G; Schmidt-Weber CB; Timmermans F; Tsilochristou O; Varga EM; Wilkinson JN; Williams A; Zhang L; Agache I; Angier E; Fernandez-Rivas M; Jutel M; Lau S; van Ree R; Ryan D; Sturm GJ; Muraro A
Allergy; 2018 Apr; 73(4):765-798. PubMed ID: 28940458
[TBL] [Abstract][Full Text] [Related]
23. Allergen immunotherapy for allergic asthma: protocol for a systematic review.
Dhami S; Nurmatov U; Agache I; Lau S; Muraro A; Jutel M; Roberts G; Akdis C; Bonini M; Calderon M; Casale T; Cavkaytar O; Cox L; Demoly P; Flood B; Hamelmann E; Izuhara K; Kalayci Ö; Kleine-Tebbe J; Nieto A; Papadopoulos N; Pfaar O; Rosenwasser L; Ryan D; Schmidt-Weber C; Szefler S; Wahn U; van Wijk RG; Wilkinson J; Sheikh A
Clin Transl Allergy; 2015; 6():5. PubMed ID: 26862389
[TBL] [Abstract][Full Text] [Related]
24. Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis.
Wilson DR; Lima MT; Durham SR
Allergy; 2005 Jan; 60(1):4-12. PubMed ID: 15575924
[TBL] [Abstract][Full Text] [Related]
25. Allergen-specific immunotherapy for pediatric asthma and rhinoconjunctivitis: a systematic review.
Kim JM; Lin SY; Suarez-Cuervo C; Chelladurai Y; Ramanathan M; Segal JB; Erekosima N
Pediatrics; 2013 Jun; 131(6):1155-67. PubMed ID: 23650298
[TBL] [Abstract][Full Text] [Related]
26. Analysis of allergen immunotherapy studies shows increased clinical efficacy in highly symptomatic patients.
Howarth P; Malling HJ; Molimard M; Devillier P
Allergy; 2012 Mar; 67(3):321-7. PubMed ID: 22142377
[TBL] [Abstract][Full Text] [Related]
27. Sublingual immunotherapy for allergic rhinitis.
Wilson DR; Torres LI; Durham SR
Cochrane Database Syst Rev; 2003; (2):CD002893. PubMed ID: 12804442
[TBL] [Abstract][Full Text] [Related]
28. Specific immunotherapy with SQ standardized grass allergen tablets in asthmatics with rhinoconjunctivitis.
Dahl R; Stender A; Rak S
Allergy; 2006 Feb; 61(2):185-90. PubMed ID: 16409194
[TBL] [Abstract][Full Text] [Related]
29. Effectiveness of subcutaneous immunotherapy for allergic rhinoconjunctivitis and asthma: a systematic review.
Erekosima N; Suarez-Cuervo C; Ramanathan M; Kim JM; Chelladurai Y; Segal JB; Lin SY
Laryngoscope; 2014 Mar; 124(3):616-27. PubMed ID: 23832632
[TBL] [Abstract][Full Text] [Related]
30. Sublingual immunotherapy for the treatment of allergic rhinoconjunctivitis and asthma: a systematic review.
Lin SY; Erekosima N; Kim JM; Ramanathan M; Suarez-Cuervo C; Chelladurai Y; Ward D; Segal JB
JAMA; 2013 Mar; 309(12):1278-88. PubMed ID: 23532243
[TBL] [Abstract][Full Text] [Related]
31. Post-treatment efficacy of discontinuous treatment with 300IR 5-grass pollen sublingual tablet in adults with grass pollen-induced allergic rhinoconjunctivitis.
Didier A; Malling HJ; Worm M; Horak F; Sussman G; Melac M; Soulié S; Zeldin RK
Clin Exp Allergy; 2013 May; 43(5):568-77. PubMed ID: 23600548
[TBL] [Abstract][Full Text] [Related]
32. Carbamylated monomeric allergoids as a therapeutic option for sublingual immunotherapy of dust mite- and grass pollen-induced allergic rhinoconjunctivitis: a systematic review of published trials with a meta-analysis of treatment using Lais® tablets.
Mösges R; Ritter B; Kayoko G; Allekotte S
Acta Dermatovenerol Alp Pannonica Adriat; 2010 Oct; 19(3):3-10. PubMed ID: 20976414
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of 2 months of allergen-specific immunotherapy with Bet v 1-derived contiguous overlapping peptides in patients with allergic rhinoconjunctivitis: Results of a phase IIb study.
Spertini F; DellaCorte G; Kettner A; de Blay F; Jacobsen L; Jutel M; Worm M; Charlon V; Reymond C
J Allergy Clin Immunol; 2016 Jul; 138(1):162-8. PubMed ID: 27373329
[TBL] [Abstract][Full Text] [Related]
34. Allergen immunotherapy for insect venom allergy: a systematic review and meta-analysis.
Dhami S; Zaman H; Varga EM; Sturm GJ; Muraro A; Akdis CA; Antolín-Amérigo D; Bilò MB; Bokanovic D; Calderon MA; Cichocka-Jarosz E; Oude Elberink JN; Gawlik R; Jakob T; Kosnik M; Lange J; Mingomataj E; Mitsias DI; Mosbech H; Ollert M; Pfaar O; Pitsios C; Pravettoni V; Roberts G; Ruëff F; Sin BA; Asaria M; Netuveli G; Sheikh A
Allergy; 2017 Mar; 72(3):342-365. PubMed ID: 28120424
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of Grass Pollen Allergen Sublingual Immunotherapy Tablets for Seasonal Allergic Rhinoconjunctivitis: A Systematic Review and Meta-analysis.
Di Bona D; Plaia A; Leto-Barone MS; La Piana S; Di Lorenzo G
JAMA Intern Med; 2015 Aug; 175(8):1301-9. PubMed ID: 26120825
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of subcutaneous and sublingual immunotherapy with grass allergens for seasonal allergic rhinitis: a meta-analysis-based comparison.
Di Bona D; Plaia A; Leto-Barone MS; La Piana S; Di Lorenzo G
J Allergy Clin Immunol; 2012 Nov; 130(5):1097-1107.e2. PubMed ID: 23021885
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of a short course of specific immunotherapy in patients with allergic rhinoconjunctivitis to ragweed pollen.
Patel P; Holdich T; Fischer von Weikersthal-Drachenberg KJ; Huber B
J Allergy Clin Immunol; 2014 Jan; 133(1):121-9.e1-2. PubMed ID: 23870670
[TBL] [Abstract][Full Text] [Related]
38. Conjunctival provocation tests: prediction of seasonal allergy.
Schröder J; Mösges R
Curr Opin Allergy Clin Immunol; 2018 Oct; 18(5):393-397. PubMed ID: 30020256
[TBL] [Abstract][Full Text] [Related]
39. Defining pollen exposure times for clinical trials of allergen immunotherapy for pollen-induced rhinoconjunctivitis - an EAACI position paper.
Pfaar O; Bastl K; Berger U; Buters J; Calderon MA; Clot B; Darsow U; Demoly P; Durham SR; Galán C; Gehrig R; Gerth van Wijk R; Jacobsen L; Klimek L; Sofiev M; Thibaudon M; Bergmann KC
Allergy; 2017 May; 72(5):713-722. PubMed ID: 27874202
[TBL] [Abstract][Full Text] [Related]
40. Canadian trial of sublingual swallow immunotherapy for ragweed rhinoconjunctivitis.
Bowen T; Greenbaum J; Charbonneau Y; Hebert J; Filderman R; Sussman G; Del Carpio J; Gold M; Keith P; Moote W; Cecchetto S; Cecchetto O; Sharp D; Broutin O; André C
Ann Allergy Asthma Immunol; 2004 Nov; 93(5):425-30. PubMed ID: 15562880
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
